Your session is about to expire
← Back to Search
DT1 Sphere Contact Lenses for Dry Eye Syndrome
Study Summary
This trial found that out of 48 participants, 25 (52.1%) were successful in refitting with DT1.
- Dry Eye Syndrome
- Contact Lens Complication
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Group 1: Dailies Total1
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there currently available vacancies for individuals wishing to participate in this trial?
"Affirmative. Clinicaltrials.gov displays the information that this medical trial, which was first published on May 23rd 2022, is actively recruiting participants. Specifically, they are looking to enroll 60 patients from 4 different sites."
How many health care facilities are conducting this research endeavor?
"Currently, 4 clinical sites are enrolling patients in this trial. Participants can find medical centres Birmingham, Pittsburg and Memphis as well as other nearby locations. For the sake of convenience, it is suggested to join a site closest to one's residence if they choose to partake in the study."
How many individuals have registered to participate in this research?
"In order to conduct the trial, Alcon Research needs 60 qualified participants. The sponsor will be running this study out of two separate medical centres: University of Alabama at Birmingham in Birmingham, Alabama and Kannarr Eye Care in Pittsburg, Kansas."
Does the recruitment criteria for this experiment extend to those aged 45 and above?
"The acceptable age range for this clinical trial is 18-40. For younger or older patients, there are 3 trials and 82 trials respectively that may be suitable options."
To what demographics is enrollment in this study open?
"This clinical trial is seeking 60 individuals aged 18 to 40 that have experienced difficulties while wearing contact lenses. Prospective participants must possess 20/20 vision or better, had worn contact lenses for at least one year prior, ceased wearing the lenses within two years due to discomfort or dryness, and scored 3 points of lower on the SPEED questionnaire. Furthermore, an updated glasses prescription less than three-years-old is required in order to be refitted with Dailies Total1 Sphere contact lens."
Share this study with friends
Copy Link
Messenger